Lifeway Foods, Inc. (LWAY) stock intrinsic value fair value estimate & owner earnings analysis

Lifeway Foods is the leading US kefir brand, making drinkable kefir, Farmer Cheese and related cultured dairy products at plants in Morton Grove and Niles, Illinois and Waukesha, Wisconsin, and selling them mostly through US grocers. Sales have grown from about $94 million in 2019 to $212 million in 2025 and roughly $130 million in the first half of 2026. The business, though, earns a thin margin on a commodity input. Raw milk is its main cost and it cannot reliably pass price swings through. In the second quarter of 2026, record sales of $66.9 million produced only $127,000 of net income. Earning power. We measure the cash an owner could take out of the business after normal reinvestment. We start from operating cash flow, strip out working-capital swings, charge stock compensation as a real cost, and deduct only the capital spending needed to maintain the plants. In 2025 the company spent $27.4 million on equipment. About $20.9 million of that was the identified Waukesha project to double capacity, which we treat as growth investment rather than upkeep. On that basis owner cash earnings were about $4.7 million in 2020, $4.7 million in 2021, $1.4 million in 2022, $10.6 million in 2023, $5.9 million in 2024 and $8.7 million in 2025. Before 2020 the company was shrinking and lost money in 2017 and 2018. We measure from 2020, when the turnaround in sales began. That window includes the 2022 milk-cost squeeze and the 2023 recovery. Its median is about $6.1 million a year, or roughly $0.40 per share before a very small interest bill. The $3.2 million 2025 gain on selling the Simple Mills stake is not counted. Base case. Earnings dropped sharply in the second quarter of 2026 as dairy, packaging and freight costs rose, so year one is set at about $4 million, below last year's level. After that, earnings return to the $6.1 million mid-cycle level and stay flat. We credit no growth from the new Waukesha capacity. It is due to finish in the fourth quarter of 2026, but there are no contracts to fill it, and the company has never run that much volume. The business is worth about $100 million. It owes about $22 million on its revolving credit line, holds about $4 million of cash beyond operating needs, and still has roughly $7.6 million of the roughly $48 million project left to pay. After those debts the shares are worth about $4.85 each. Bear case. This case repeats the 2017-2019 episode, when sales fell about 25% from $124 million to $94 million and owner earnings turned negative for two years. Here it happens just as the company carries new debt and higher fixed costs from a doubled plant. Earnings fall to about $2 million, then to losses of about $2 million and $1 million, recover to about $2 million, and settle around $3 million a year. Earning power then erodes slowly, about 2% a year. In this case the lender relief on the fixed-charge covenant expires in June 2027, which we charge as roughly $3 million of extra financing cost. The business is worth about $33 million and owes roughly $29 million, so the shares are worth only about $0.29. The company would come close to owing what it is worth. Bull case. The doubled Waukesha plant runs efficiently, sales keep growing at the pace of the past five years for three more years, and margins return to the 2023 level. Owner earnings climb to about $12.75 million by year four and then hold flat. The business is worth about $200 million less the same $25 million or so of debt, about $11.50 a share. Ownership. Danone holds about 23% of the shares, and its shares are registered for resale. The Smolyansky family holds about 44% in total but is divided. A shareholder rights plan adopted in November 2024 remains in place, and litigation over the 1999 stockholders agreement is stayed under a September 2025 cooperation agreement. Outside owners have little influence, and a large block of stock could come to market. Margin-of-safety price. We are only moderately confident in the earnings level. It has swung between a loss and $10.6 million within eight years, and the latest quarter shows how quickly a milk-cost spike erases profit. The worst plausible outcome is a dairy-cost squeeze that coincides with a slow ramp at Waukesha. The company would then be servicing new borrowings from little or no cash flow just as its covenant relief ends. The assets are hard plants with a lasting brand, and debt is modest relative to the business, so we expect it to survive with dilution or forced selling rather than collapse. If we are wrong about the mid-cycle level and the plant adds nothing, the shares are worth roughly $3 to $5. If the bear episode repeats, they are worth well under $1. The company pays no dividend, so any return in the cases has to come from the business recovering its normal earnings, which could take two to three years. The margin-of-safety price is $2.00; from that price the base case implies about 20% a year over three years. The price also leaves room for the margin to stay compressed for longer than we expect. Above $2.00, a three-year stall in margins would leave no way to reach the target.